BlackRock, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for Stoke Therapeutics, Inc. Common Stock (STOK)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Stoke Therapeutics, Inc. Common Stock
Symbol: STOK
Shares outstanding: 53,774,724 shares
Disclosed Ownership: 3,118,934 shares
Ownership: 5.8%
Form type: SCHEDULE 13G/A
Filing time: 16 Apr 2025, 18:41:49 UTC
Date of event: 31 Mar 2025
Next filing: 17 Oct 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5.8%	3,118,934	3,081,104	0	Spencer Fleming	Managing Director